Vulcan Materials
VMC NYSE Construction Materials Financials FY2016βFY2025
Vulcan Materials' revenue rose 7.1% to $7.9 billion in fiscal 2025. Its operating margin was 20.4%, up from 18.4% a year earlier. Free cash flow was $1.1 billion, up 40.8%. It paid out $698 million in dividends and buybacks, 62% of free cash flow. The diluted share count fell 0.3%.
What Vulcan Materials does
No business description yet.
- Legal name
- VULCAN MATERIALS COMPANY
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-009546
0001396009
Revenue and margins
Vulcan Materials had $7.9B of revenue in fiscal 2025, up 7.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 11.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 14.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Vulcan Materials returned $698M to shareholders in fiscal 2025, 62% of free cash flow. The diluted share count fell 0.3%.
Value Vulcan Materials yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$4.2B and divides by 132.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 31.2x Β· peers 14.4x Β· sector 20.1x.
Balance sheet
Cash, debt and the ratios that show how comfortably Vulcan Materials can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $235M | $161M | $931M | $560M | $183M |
| Debt incl. finance leases | $4.0B | $4.0B | $3.9B | $5.3B | $4.4B |
| Net debt / EBITDA | 2.5x | 2.5x | 1.5x | 2.4x | 1.8x |
| Debt / equity | 0.6x | 0.6x | 0.5x | 0.7x | 0.5x |
| Interest coverage | 6.8x | 5.6x | 7.3x | 7.1x | 6.8x |
| Current ratio | 2.2x | 2.0x | 3.2x | 1.8x | 2.7x |
| Quick ratio | 1.5x | 1.4x | 2.4x | 1.3x | 2.0x |
| Total assets | $13.7B | $14.2B | $14.5B | $17.1B | $16.7B |
| Total liabilities | $7.1B | $7.3B | $7.0B | $9.0B | $8.2B |
| Shareholders' equity | $6.5B | $6.9B | $7.5B | $8.1B | $8.5B |
| Net debt (β = net cash) | $3.7B | $3.9B | $3.0B | $4.8B | $4.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$15.0M
7 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | Hill J ThomasDirector | Sold | 14,000 | $276.17 | $3.9M | Form 4 |
| Aug 7, 2026 | David P ClementSenior Vice President | Sold | 2,000 | $285.10 | $0.6M | Form 4 |
| Jun 15, 2026 | David P ClementSenior Vice President | Sold | 2,212 | $292.29 | $0.6M | Form 4 |
| Feb 20, 2026 | Melissa H. AndersonDirector | Sold | 1,137 | $303.72 | $0.3M | Form 4 |
| Dec 11, 2025 | Thompson S Baker IIPresident | Sold | 7,135 | $300.81 | $2.1M | Form 4 |
| Dec 10, 2025 | Denson N. Franklin IIISVP, Gen. Counsel & Secretary | Sold | 665 | $295.00 | $0.2M | Form 4 |
| Nov 19, 2025 | David P ClementSenior Vice President | Sold | 2,000 | $288.55 | $0.6M | Form 4 |
| Nov 12, 2025 | Thompson S Baker IIPresident | Sold | 4,853 | $295.63 | $1.4M | Form 4 |
| Nov 10, 2025 | Grayson HallDirector | Sold | 4,658 | $290.74 | $1.4M | Form 4 |
| Nov 10, 2025 | Thompson S Baker IIPresident | Sold | 4,243 | $289.76 | $1.2M | Form 4 |
| Nov 7, 2025 | Stanley G BassChief Strategy Officer | Sold | 3,333 | $288.00 | $1.0M | Form 4 |
| Nov 4, 2025 | Thompson S Baker IIPresident | Sold | 5,818 | $292.26 | $1.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 5 / 9 | 8 / 9 |
| Accruals ratio | β4.2% | β3.1% | β4.4% |
| Altman Z'' | 3.59 | 2.88 | 3.48 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Vulcan Materials VMC | $34.3B | 7.1% | 20.4% | 14.3% | 9.8% | 31.2x | 8 | |
| Martin Marietta Materials MLM | $30.5B | 8.6% | 23.4% | 15.9% | 7.7% | 12.5x | 7 | Compare β |
| Knife River KNF | $3.0B | 8.5% | 9.1% | β2.2% | 9.1% | 21.7x | 3 | Compare β |
| Eagle Materials EXP | $5.4B | 2.1% | β | 8.6% | 16.3% | 13.8x | 5 | Compare β |
| CRH CRH | $56.8B | 5.3% | 14.5% | 7.8% | 11.8% | 15.0x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.6B | $3.9B | $4.4B | $4.9B | $4.9B | $5.6B | $7.3B | $7.8B | $7.4B | $7.9B |
| Gross profit | $989M | $994M | $1.1B | $1.3B | $1.3B | $1.4B | $1.6B | $1.9B | $2.0B | $2.2B |
| Operating income | $666M | $639M | $748M | $878M | $896M | $1.0B | $951M | $1.4B | $1.4B | $1.6B |
| Interest expense | $134M | $296M | $138M | $130M | $136M | $149M | $169M | $196M | $191M | $240M |
| Pretax income | $547M | $361M | $623M | $758M | $744M | $874M | $788M | $1.2B | $1.2B | $1.4B |
| Income tax | $125M | β$232M | $105M | $135M | $156M | $200M | $193M | $299M | $251M | $308M |
| Net income | $420M | $601M | $516M | $618M | $585M | $671M | $576M | $933M | $912M | $1.1B |
| Diluted EPS | $3.09 | $4.46 | $3.85 | $4.63 | $4.39 | $5.02 | $4.31 | $6.98 | $6.85 | $8.11 |
| Diluted shares | 0.14B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B |
| Cash flow | ||||||||||
| Cash from operations | $645M | $645M | $833M | $984M | $1.1B | $1.0B | $1.1B | $1.5B | $1.4B | $1.8B |
| Capital expenditure | $350M | $460M | $469M | $384M | $362M | $451M | $613M | $873M | $604M | $678M |
| Free cash flow | $294M | $185M | $364M | $600M | $708M | $561M | $536M | $664M | $806M | $1.1B |
| Depreciation and amortization | $285M | $306M | $346M | $375M | $397M | $463M | $588M | $617M | $632M | $749M |
| Stock-based compensation | $20.7M | $26.6M | $25.2M | $31.8M | $33.0M | $34.7M | $41.1M | $63.2M | $53.4M | $63.1M |
| Acquisitions | $32.5M | $1.1B | $221M | $44.2M | $43.2M | $1.6B | $529M | $0.9M | $2.3B | $13.5M |
| Share buybacks | $162M | $60.3M | $134M | $2.6M | $26.1M | $0.0M | $0.0M | $200M | $68.8M | $438M |
| Dividends paid | $106M | $132M | $148M | $164M | $180M | $196M | $213M | $228M | $244M | $260M |
| Dividends and buybacks | $268M | $193M | $282M | $167M | $206M | $196M | $213M | $428M | $313M | $698M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $259M | $142M | $40.0M | $272M | $1.2B | $235M | $161M | $931M | $560M | $183M |
| Total debt | $2.0B | $2.9B | $2.9B | $2.8B | $3.3B | $3.9B | $4.0B | $3.9B | $5.3B | $4.4B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $1.2M | $6.2M | $95.9M | $57.1M | $29.1M | $20.4M | $10.8M |
| Current assets | $1.1B | $1.2B | $1.1B | $1.4B | $2.3B | $1.7B | $1.9B | $2.5B | $2.3B | $2.6B |
| Current liabilities | $372M | $443M | $603M | $536M | $1.0B | $769M | $957M | $798M | $1.2B | $956M |
| Inventory | $346M | $384M | $429M | $458M | $449M | $521M | $579M | $616M | $682M | $681M |
| Property and equipment, net | $3.3B | $3.9B | $4.2B | $4.3B | $4.4B | $5.5B | $6.1B | $6.2B | $8.5B | $8.1B |
| Total assets | $8.5B | $9.5B | $9.8B | $10.6B | $11.7B | $13.7B | $14.2B | $14.5B | $17.1B | $16.7B |
| Total liabilities | $3.9B | $4.5B | $4.6B | $5.0B | $5.7B | $7.1B | $7.3B | $7.0B | $9.0B | $8.2B |
| Shareholders' equity | $4.6B | $5.0B | $5.2B | $5.6B | $6.0B | $6.5B | $6.9B | $7.5B | $8.1B | $8.5B |
| Margins | ||||||||||
| Gross margin | 27.5% | 25.5% | 25.1% | 25.5% | 26.4% | 24.7% | 21.3% | 25.0% | 27.0% | 27.4% |
| Operating margin | 18.5% | 16.4% | 17.1% | 17.8% | 18.4% | 18.2% | 13.0% | 18.3% | 18.4% | 20.4% |
| EBITDA margin | 26.5% | 24.3% | 25.0% | 25.4% | 26.6% | 26.5% | 21.0% | 26.3% | 26.9% | 29.8% |
| Net margin | 11.7% | 15.5% | 11.8% | 12.5% | 12.0% | 12.1% | 7.9% | 12.0% | 12.3% | 13.6% |
| FCF margin | 8.2% | 4.8% | 8.3% | 12.2% | 14.6% | 10.1% | 7.3% | 8.5% | 10.9% | 14.3% |
| Returns | ||||||||||
| Return on capital | 8.3% | 9.1% | 7.9% | 8.9% | 8.7% | 8.5% | 6.8% | 10.2% | 9.2% | 9.8% |
| Return on capital employed | 8.3% | 7.5% | 8.2% | 9.1% | 8.6% | 8.6% | 7.3% | 10.6% | 9.2% | 10.3% |
| Return on equity | 9.3% | 12.6% | 10.1% | 11.4% | 10.0% | 10.7% | 8.5% | 13.0% | 11.7% | 12.9% |
| Return on assets | 5.0% | 6.7% | 5.3% | 6.0% | 5.2% | 5.3% | 4.1% | 6.5% | 5.8% | 6.4% |
| Growth | ||||||||||
| Revenue growth | 5.0% | 8.3% | 12.7% | 12.5% | β1.5% | 14.3% | 31.8% | 6.4% | β4.7% | 7.1% |
| Net income growth | 89.7% | 43.3% | β14.2% | 19.8% | β5.4% | 14.8% | β14.2% | 62.1% | β2.3% | 18.1% |
| EPS growth | 88.4% | 44.3% | β13.7% | 20.3% | β5.2% | 14.4% | β14.1% | 62.0% | β1.9% | 18.4% |
| FCF growth | 27.9% | β37.1% | 96.5% | 65.0% | 18.0% | β20.8% | β4.5% | 24.0% | 21.4% | 40.8% |
| Share count change | 0.5% | β0.7% | β0.7% | β0.4% | β0.2% | 0.2% | 0.1% | 0.1% | β0.5% | β0.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.8x | 2.9x | 2.6x | 2.0x | 1.6x | 2.5x | 2.5x | 1.5x | 2.4x | 1.8x |
| Debt / equity | 0.4x | 0.6x | 0.6x | 0.5x | 0.6x | 0.6x | 0.6x | 0.5x | 0.7x | 0.5x |
| Interest coverage | 5.0x | 2.2x | 5.4x | 6.7x | 6.6x | 6.8x | 5.6x | 7.3x | 7.1x | 6.8x |
| Current ratio | 3.1x | 2.7x | 1.8x | 2.6x | 2.2x | 2.2x | 2.0x | 3.2x | 1.8x | 2.7x |
| Quick ratio | 2.1x | 1.8x | 1.1x | 1.7x | 1.8x | 1.5x | 1.4x | 2.4x | 1.3x | 2.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 9.8% | 11.8% | 10.7% | 7.8% | 7.5% | 8.1% | 8.4% | 11.2% | 8.1% | 8.5% |
| Stock comp / revenue | 0.6% | 0.7% | 0.6% | 0.7% | 0.7% | 0.6% | 0.6% | 0.8% | 0.7% | 0.8% |
| Payouts / FCF | 91.0% | 104.1% | 77.6% | 27.8% | 29.1% | 35.0% | 39.7% | 64.5% | 38.9% | 61.5% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 6.0 | 6.0 | 9.0 | 5.0 | 6.0 | 5.0 | 8.0 | 5.0 | 8.0 |
| Altman Z'' | 3.0 | 2.9 | 2.8 | 3.1 | 3.2 | 2.8 | 2.8 | 3.6 | 2.9 | 3.5 |
| Accruals ratio | β2.7% | β0.5% | β3.3% | β3.6% | β4.4% | β2.7% | β4.1% | β4.2% | β3.1% | β4.4% |
Source: SEC EDGAR XBRL filings (CIK 0001396009). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.